Prescription drug pricing Pharmacy Benefit Managers (PBM) and Pharmacy Policy and Reimbursement Issues Prescription Drug Rebate Issues Tax Reform Implementation Issues TRICARE Policy Issues including Telehealth, Value-Based Care, and T-5 Transition NDAA Implementation Policy Issues Veterans Healthcare and Policy Issues Implementation of National Defense Authorization Act for Fiscal Year 2024 Public Law No: 118-31 Medicare Advantage (MA) Policy and Reimbursement Announcement of Calendar Year (CY) 2024 Medicare Advantage (MA) Capitation Rates and Part C and Part D Payment Policies Medicare Part D Issues Medicaid Policy Issues Including Redeterminations and Dual Eligibles Pharmacy Benefit Managers (PBM) and Pharmacy Policy and Reimbursement Issues Home Health Policy and Reimbursement Issues Prescription Drug Rebate Issues Implementation of Inflation Reduction Act of 2022 Public Law No. 117-169 S. 3018/H.R. 3173, Improving Seniors Timely Access to Care Act (117th Congress) Prior Authorization Policy and Regulatory Issues Health Data, Technology, and Interoperability: Certification Program Updates, Algorithm Transparency, and Information Sharing (RIN 0955-AA03) CMS Guidance on Direct Negotiation (Official Title: Medicare Drug Price Negotiation Program: Initial Memorandum, Implementation of Sections 1191 - 1198 of the Social Security Act for Initial Price Applicability Year 2026, and Solicitation of Comments) CMS-4185-F2 Medicare Advantage Risk Adjustment Data Validation Final Rule Primary Care and Value-Based Care Policy and Reimbursement Clinical Policy Issues Including Workforce and Mental Health FY 2024 Hospital Inpatient Prospective Payment System (IPPS) and Long-Term Care Hospital Prospective Payment System (LTCH PPS) Final Rule (CMS-1785-F and CMS-1788-F) Remedy for the 340B-Acquired Drug Payment Policy for Calendar Years 2018-2022 Proposed Rule (CMS 1793-P) H.R. 4822, Health Care Price Transparency Act of 2023 Contract Year 2025 Policy and Technical Changes to the Medicare Advantage Plan Program, Medicare Prescription Drug Benefit Program, Medicare Cost Plan Program, and Programs of All-Inclusive Care for the Elderly, and Health Information Technology Standards (CMS-4205-P) CY 2024 Home Health Prospective Payment System Final Rule (CMS-1780-F) CY 2024 Medicare Hospital Outpatient Prospective Payment System and Ambulatory Surgical Center Payment System Final Rule (CMS 1786-FC) CY 2024 Medicare Physician Fee Schedule Final Rule (CMS-1784-F) Hospital Outpatient Prospective Payment System (OPPS): Remedy for the 340B-Acquired Drug Payment Policy for Calendar Years 2018-2022 Final Rule (CMS 1793-F)
PHA - Pharmacy TAX - Taxation/Internal Revenue Code DEF - Defense MMM - Medicare/Medicaid
136 - Centers For Medicare and Medicaid Services (CMS) 135 - Food & Drug Administration (FDA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 18 - Office of Management & Budget (OMB) 1 - SENATE 12 - White House Office 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 41 - Treasury, Dept of 12 - White House Office 25 - Defense, Dept of (DOD) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 42 - Veterans Affairs, Dept of (VA) 136 - Centers For Medicare and Medicaid Services (CMS) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 18 - Office of Management & Budget (OMB) 1 - SENATE 12 - White House Office
HUMANA, INC.
500 WEST MAIN STREET, LOUISVILLE, KY, 40202, US
JEFFREY LUNGREN VERONICA JACKSON RACHEL MAGNUSON VERONICA JACKSON JEFFREY LUNGREN RACHEL MAGNUSON VERONICA JACKSON JEFFREY LUNGREN RACHEL MAGNUSON VERONICA JACKSON JEFFREY LUNGREN RACHEL MAGNUSON